Back to Search
ALMA FE HOUGHTON, M.D.
M.D.
Internal Medicine Physician
NPI: 1679006852IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD61052145(WA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2017
Research & Publications (20)
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
PMID 11275375·Pain·2001
7-preclinical
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
PMID 19496531·Cancer Immun·2009
3-trial
Epithelial cell apoptosis causes acute lung injury masquerading as emphysema.
PMID 19188661·Am J Respir Cell Mol Biol·2009
4-observational
Patency of infra-inguinal vein grafts--effect of intraoperative Doppler assessment and a graft surveillance program.
PMID 19497506·J Vasc Surg·2009
8-other
Development of effective vaccines for old mice in a tumor model.
PMID 19103244·Vaccine·2009
7-preclinical
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.
PMID 19332877·J Exp Med·2009
7-preclinical
Addressing climate change and local public health: the Austin Climate Protection Program and the CDC Working Group on Climate Change collaboration.
PMID 19408428·J Environ Health·2009
8-other
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.
PMID 19414558·J Exp Med·2009
7-preclinical
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
PMID 19011222·Blood·2009
7-preclinical
Neutrophil elastase is needed for neutrophil emigration into lungs in ventilator-induced lung injury.
PMID 18276796·Am J Respir Cell Mol Biol·2008
7-preclinical
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
PMID 18797450·Mol Ther·2008
3-trial
Mechanisms of immunization against cancer using chimeric antigens.
PMID 18301399·Mol Ther·2008
7-preclinical
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3.
PMID 18715932·J Virol·2008
7-preclinical
Frequent p16-independent inactivation of p14ARF in human melanoma.
PMID 18505964·J Natl Cancer Inst·2008
7-preclinical
A single-institution validation of the AJCC staging system for stage IV melanoma.
PMID 18465172·Ann Surg Oncol·2008
4-observational
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
PMID 19047169·Cancer Res·2008
7-preclinical
Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.
PMID 18798552·Int J Cancer·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4500 SE COLUMBIA PALISADES DR
CAMAS, WA 98607 - Phone
- (360) 882-2778
Quick Facts
- NPI
- 1679006852
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile